HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR.

AbstractBACKGROUND AND OBJECTIVE:
Antibodies to human leucocyte antigens (HLA) and human polymorphonuclear neutrophil (PMN) antigens are considered etiologic agents of transfusion-related acute lung injury (TRALI). The aim of this study was to clarify the role of anti-HLA DR antibodies in the pathophysiology of TRALI and the ability of purified soluble HLA DR (psHLA DR) to inhibit the release of cytokines in an in vitro model.
MATERIALS AND METHODS:
A coculture of human pulmonary microvascular endothelial cells (HMVEC) and monocytes in the presence of serum containing anti-HLA DR alloantibodies previously associated with cases of TRALI was used as an in vitro TRALI model. The release of leukotriene B(4) (LTB(4)) and tumour necrosis factor-alpha (TNF-alpha), the apoptosis of HMVECs were measured.
RESULTS:
The release of LTB(4) and TNF-alpha and apoptosis of HMVECs were observed in the model. The addition of psHLA DR markedly reduced the release of LTB(4) and TNF-alpha and inhibited apoptosis of HMVECs.
CONCLUSION:
These results support the critical role of anti-HLA DR alloantibodies in the pathogenesis of TRALI and suggest that the soluble HLA DR could inhibit TRALI development caused by anti-HLA DR alloantibodies.
AuthorsM Nishimura, S Hashimoto, M Satake, H Okazaki, K Tadokoro
JournalVox sanguinis (Vox Sang) Vol. 93 Issue 1 Pg. 78-82 (Jul 2007) ISSN: 0042-9007 [Print] England
PMID17547569 (Publication Type: Journal Article)
Chemical References
  • HLA-DR Antigens
  • Isoantibodies
  • Tumor Necrosis Factor-alpha
  • Leukotriene B4
Topics
  • Antibody Formation (drug effects, immunology)
  • Apoptosis (drug effects, immunology)
  • Cells, Cultured
  • Endothelial Cells (immunology, pathology)
  • HLA-DR Antigens (immunology, isolation & purification, pharmacology, therapeutic use)
  • Humans
  • Isoantibodies (immunology)
  • Leukotriene B4 (immunology)
  • Lung (blood supply, immunology, pathology)
  • Models, Biological
  • Monocytes (immunology, pathology)
  • Neutrophils (immunology, pathology)
  • Respiratory Distress Syndrome (drug therapy, etiology, immunology, pathology)
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: